- Home
- LXRX vs RHLD Comparison
LXRX vs RHLD Comparison
Compare LXRX & RHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- RHLD
- Stock Information
- Founded
- LXRX 1995
- RHLD 2024
- Country
- LXRX United States
- RHLD United States
- Employees
- LXRX N/A
- RHLD N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- RHLD
- Sector
- LXRX Health Care
- RHLD
- Exchange
- LXRX Nasdaq
- RHLD NYSE
- Market Cap
- LXRX 228.8M
- RHLD 217.1M
- IPO Year
- LXRX 2000
- RHLD N/A
- Fundamental
- Price
- LXRX $0.63
- RHLD $34.49
- Analyst Decision
- LXRX Buy
- RHLD
- Analyst Count
- LXRX 4
- RHLD 0
- Target Price
- LXRX $3.67
- RHLD N/A
- AVG Volume (30 Days)
- LXRX 4.1M
- RHLD 27.0K
- Earning Date
- LXRX 05-13-2025
- RHLD 05-12-2025
- Dividend Yield
- LXRX N/A
- RHLD N/A
- EPS Growth
- LXRX N/A
- RHLD N/A
- EPS
- LXRX N/A
- RHLD 12.54
- Revenue
- LXRX $31,213,000.00
- RHLD $420,450,000.00
- Revenue This Year
- LXRX N/A
- RHLD N/A
- Revenue Next Year
- LXRX $46.60
- RHLD N/A
- P/E Ratio
- LXRX N/A
- RHLD $2.74
- Revenue Growth
- LXRX 1251.21
- RHLD 11.09
- 52 Week Low
- LXRX $0.28
- RHLD $24.22
- 52 Week High
- LXRX $2.45
- RHLD $54.05
- Technical
- Relative Strength Index (RSI)
- LXRX 51.48
- RHLD N/A
- Support Level
- LXRX $0.62
- RHLD N/A
- Resistance Level
- LXRX $0.72
- RHLD N/A
- Average True Range (ATR)
- LXRX 0.05
- RHLD 0.00
- MACD
- LXRX -0.00
- RHLD 0.00
- Stochastic Oscillator
- LXRX 59.81
- RHLD 0.00
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About RHLD RESOLUTE HOLDINGS MANAGEMENT INC
Resolute Holdings Management Inc is provide operating management services. The company has two operating segments and two reportable segments: Payment Card and Arculus. Payment Card generates its revenue through the production and sale of metal payment cards while Arculus generates its revenue through the production and sale of metal payment or nonpayment cards containing Arculus technology for authentication and/or digital asset cold storage and related services. The company generates maximum revenue Domestically.